Increasing Incidences of Cancer Driving Epigenetics Drugs and Diagnostic Technologies Market

Published By : 18 Nov 2016 | Published By : QYRESEARCH

Epigenetics is a study of chemical modifications and particular genes of an organism. Owing to defects in gene function, diseases such as diabetes, cancer, metabolic disorders, and autoimmune diseases occur in the human body. Epigenetics drugs are those that can reverse the abnormal gene behavior by altering the sequence of its DNA or epigenetic programming. Thus, the development of epigenetics technology is a good news for many patients worldwide and this is driving the market for epigenetics drugs and diagnostic technologies. 

The rising demand for the treatment of oncology and non-oncology conditions is one of the key drivers of the market. Cancer is a leading cause of deaths worldwide and this will create a heightened demand for epigenetics drugs and diagnostic technologies. These drugs are also being used for the treatment of central nervous system disorders, thus fueling the growth of the market.

Genericization of Popular Drugs to Pose a Challenge for Epigenetics Drugs and Diagnostic Technologies Market

The patent expiration of three out of four key drugs that were present in the market have expired recently. Genericization has resulted in the reduction of the prices of these drugs and this is impacting the market in a negative way. On the other hand, the development of several new diagnostic tools has made it possible to easily identify the target and patients are benefitting from targeted therapies. HDACs and DNMTs are expected to become potential targets for therapeutics in treating various human disorders and this will ensure the growth of the market in the coming years.

North America Leading in Epigenetics Drugs and Diagnostic Technologies Market

The North American epigenetics drugs and diagnostic technologies market not only led in the past but is expected to continue in its leading position in the coming years. The market in North America is driven by rising incidence of cancer and increasing funding by governments to support research programs. Moreover, manufacturers are developing newer diagnostic tools and this will further help the market to grow for the upcoming years.

Back To Top